These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24306025)

  • 41. Development of leprosy in a patient with rheumatoid arthritis during treatment with etanercept: a case report.
    Lluch P; Urruticoechea A; Lluch J; Moll MC; Matos M; Benet JM; Ene L; Cañete JD
    Semin Arthritis Rheum; 2012 Oct; 42(2):127-30. PubMed ID: 22542278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
    Mohan AK; Coté TR; Block JA; Manadan AM; Siegel JN; Braun MM
    Clin Infect Dis; 2004 Aug; 39(3):295-9. PubMed ID: 15306993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept?
    Luzi G; Laganà B; Salemi S; Di Rosa R
    Clin Ter; 2009; 160(2):121-3. PubMed ID: 19452100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
    Carroll MB; Bond MI
    Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
    Sakaida H; Komase Y; Takemura T
    Mod Rheumatol; 2010 Dec; 20(6):611-6. PubMed ID: 20585825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.
    Cunnane G; Warnock M; Fye KH; Daikh DI
    Arthritis Rheum; 2002 Aug; 47(4):445-9. PubMed ID: 12209493
    [No Abstract]   [Full Text] [Related]  

  • 48. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
    Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
    Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al.
    van der Laken CJ; Lems WF; van Soesbergen RM; van der Sande JJ; Dijkmans BA
    Arthritis Rheum; 2003 Jan; 48(1):269-70. PubMed ID: 12528130
    [No Abstract]   [Full Text] [Related]  

  • 50. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.
    Curtis JR; Patkar N; Xie A; Martin C; Allison JJ; Saag M; Shatin D; Saag KG
    Arthritis Rheum; 2007 Apr; 56(4):1125-33. PubMed ID: 17393394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
    Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
    Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatotoxicity associated with etanercept in psoriatic arthritis.
    Leak AM; Rincon-Aznar B
    J Rheumatol; 2008 Nov; 35(11):2286-7. PubMed ID: 19004062
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment.
    Lin KC; Liang CD; Yang KD; Yu HR; Kuo HC
    Rheumatol Int; 2012 May; 32(5):1383-5. PubMed ID: 20349235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etanercept: An overview.
    Goffe B; Cather JC
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S105-11. PubMed ID: 12894133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycobacterium mucogenicum: report of a skin infection associated with etanercept.
    Shehan JM; Sarma DP
    Dermatol Online J; 2008 Jan; 14(1):5. PubMed ID: 18319022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis.
    Chainani-Wu N; Chang C; Gross AJ; Yom SS; Silverman S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e261-3. PubMed ID: 24528797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 59. Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis.
    Gerster JC; Dudler J
    Clin Rheumatol; 2004 Dec; 23(6):570-1. PubMed ID: 15278747
    [No Abstract]   [Full Text] [Related]  

  • 60. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
    Duffy TN; Genta M; Moll S; Martin PY; Gabay C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.